US PBM Reform: ‘Bust Them Up’ A Theme For 2025?

  • Aug 08, 2024

    A House Committee on Oversight and Accountability hearing on potential PBM reform legislation suggests there remains strong, bipartisan interest in crafting legislation that could have a significant impact on the sector, but also that any substantive actions will not come before next year.

    The committee heard testimony from executives of the “big three” pharmacy benefit management companies, CVS Caremark, Express Scripts and United/Optum Rx, at its July 23 hearing on “transparency and accountability.” The hearing was the third in a series from the committee after previous sessions were held in May and September 2023.

    Read more
    © 2024 MMIT
  • Laura Helbling

    Laura is the director of research at Prevision Policy and a senior writer at Pink Sheet. She has a degree in magazine journalism from the University of Missouri School of Journalism.

The Latest
Meet Our Reporters

Meet Our Reporters

×